New Drug Vasculotide Effective Against Multiple Strains of Influenza Including Swine Flu

by Bidita Debnath on  June 7, 2015 at 12:50 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Scientists in Canada have developed a new drug that offers an unconventional approach to beat the flu virus.
New Drug Vasculotide Effective Against Multiple Strains of Influenza Including Swine Flu
New Drug Vasculotide Effective Against Multiple Strains of Influenza Including Swine Flu

The researchers who found the drug was effective in two different strains of mice and three different strains of flu believe the drug could be effective in animals other than mice, including humans.

Instead of targeting the virus that causes flu, the new drug can prevent the blood vessels from leaking fluid into the lung's air sacs.

People who die from the flu actually die from respiratory failure, when the lung's tiny blood vessels start leaking fluid into the lung's air sacs. The new drug, Vasculotide, developed by researchers at Sunnybrook Hospital in Toronto acts on the endothelial cells that line the blood vessels.

The drug was effective against multiple strains of influenza, including the 2009 swine flu pandemic strain.

"While this research was conducted in mice, I found the results exciting since the drug was effective in two different strains of mice and three different strains of flu," said Warren Lee, a researcher with St. Michael's Hospital's Keenan Research Center for Biomedical Sciences, who tested the new drug on mice.

As the mechanism of blood vessels leaking into lungs is common throughout animals, Lee was optimistic that the drug could be effective in animals other than mice, including humans.

Without the drug, 100% of the mice died within one week. With the drug, more than 80% survived. The drug worked even if it was administered days after the infection began.

The drug worked alone and in combination with antivirals and it worked without compromising the body's ability to mount an immune response to the virus.

The study appeared in the journal Scientific Reports.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Hib Vaccine Clinical Trials - Different Phases of the trial Signature Drug Toxicity Flu Swine Flu Reye’s Syndrome Health Risks of Eating Pork Preventing Flu: Good Health Habits Can Help Stop Germs 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive